INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 46m ago
HOUSE PTR6m ago
SEC 13F6m ago
ROBINHOOD CHAIN6m ago
ZY
Corporate insider

Zoghbi Huda Y

DirectorCIK 0001681643

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score57
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
ZY
Zoghbi Huda YDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.83M
7,439 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.Director · Nov 5, 2026
57
ZY
Zoghbi Huda YDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL
$6.73M
6,939 sh
Nov 3, 2026
Nov 5, 2026
traded Nov 3, 2026
+2d
SEC FORM 4

Evidence

50
ZY
Zoghbi Huda YDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$486K
500 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence

9
ZY
Zoghbi Huda YDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,439 sh
Nov 3, 2026Nov 5, 2026
traded Nov 3, 2026
+2dSEC FORM 4

Evidence